0
Signin
countryflagCA

888-969-2592

RY 172.7 -0.1792% SHOP 152.38 -3.7762% TD 74.49 -0.4144% ENB 58.66 0.2906% BN 80.21 0.2124% TRI 235.76 -0.7034% CNQ 42.27 -1.3305% CP 102.81 -2.4851% CNR 145.02 -0.9426% BMO 139.15 0.5855% BNS 77.045 -0.149% CSU 4497.2998 0.6756% CM 92.23 -0.335% MFC 43.28 0.8858% ATD 79.0 -1.1882% NGT 53.35 -1.8038% TRP 65.26 0.215% SU 49.61 -1.411% WCN 251.65 -0.2181% L 191.14 0.1205%

MEDIFAST INC

Consumer Cyclical US MED

17.15USD
-0.62(3.49%)

Last update at 2024-12-19T18:49:00Z

Day Range

17.0017.92
LowHigh

52 Week Range

61.94124.20
LowHigh

Fundamentals

  • Previous Close 17.77
  • Market Cap742.44M
  • Volume142403
  • P/E Ratio6.07
  • Dividend Yield9.90%
  • EBITDA163.03M
  • Revenue TTM1218.28M
  • Revenue Per Share TTM111.89
  • Gross Profit TTM 1140.41M
  • Diluted EPS TTM10.98

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 184.06M 216.13M 134.26M 92.36M 70.55M
Minority interest - - - - -
Net income 143.57M 164.03M 102.86M 77.92M 55.79M
Selling general administrative 955.61M 911.36M 563.66M 445.82M 310.84M
Selling and marketing expenses - - - - -
Gross profit 1140.41M 1127.60M 697.82M 536.86M 379.90M
Reconciled depreciation 10.98M 6.81M 7.27M 4.62M 4.43M
Ebit 184.81M 216.24M 126.89M 86.42M 64.63M
Ebitda 195.79M 223.05M 134.16M 91.04M 69.06M
Depreciation and amortization 10.98M 6.81M 7.27M 4.62M 4.43M
Non operating income net other -0.04600M 0.12M -0.14000M 0.03M 0.18M
Operating income 184.81M 216.24M 134.16M 91.04M 69.06M
Other operating expenses 1413.77M 1309.85M 800.68M 622.63M 431.94M
Interest expense 0.70M 0.11M 7.38M 5.95M 1.31M
Tax provision 40.49M 52.10M 31.41M 14.45M 14.76M
Interest income 0.70M 0.23M 0.25M 1.29M 1.31M
Net interest income -0.70100M -0.23100M 0.25M 1.29M 1.31M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 40.49M 52.10M 31.41M 14.45M 14.76M
Total revenue 1598.58M 1526.09M 934.84M 713.67M 501.00M
Total operating expenses 955.61M 911.36M 563.66M 445.82M 310.84M
Cost of revenue 458.16M 398.49M 237.03M 176.81M 121.10M
Total other income expense net -0.74700M -0.11200M 0.11M 1.32M 0.18M
Discontinued operations - - - - -
Net income from continuing ops 143.57M 164.03M 102.86M 77.92M 55.79M
Net income applicable to common shares 143.57M 164.03M 102.86M 77.92M 55.79M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 316.21M 398.33M 276.08M 194.65M 169.43M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 16.24M 17.28M 5.86M 11.27M 4.59M
Total liab 161.17M 195.85M 118.84M 89.82M 60.32M
Total stockholder equity 155.04M 202.47M 157.25M 104.83M 109.11M
Deferred long term liab - - - - -
Other current liab 69.09M 84.36M 64.30M 49.28M 38.51M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings 139.85M 190.33M 154.35M 168.79M 131.34M
Other liab - - - - -
Good will - - - - -
Other assets 17.78M 10.87M 14.14M 1.66M 4.16M
Cash 87.69M 104.18M 163.72M 76.97M 81.36M
Cash and equivalents 87.69M 104.18M 163.72M 76.97M 81.36M
Total current liabilities 140.89M 169.83M 111.35M 79.39M 60.32M
Current deferred revenue 7.36M 8.05M 7.61M 4.33M -
Net debt -61.64000M -71.64000M -152.56200M -63.37300M -81.36400M
Short term debt 5.78M 6.52M 3.67M 3.17M 0.00000M
Short long term debt - - - - -
Short long term debt total 26.05M 32.54M 11.16M 13.60M -
Other stockholder equity 15.16M 12.02M 2.84M -63.99300M -22.07700M
Property plant equipment 57.19M 56.13M 27.63M 26.04M 19.75M
Total current assets 222.78M 306.87M 234.31M 154.15M 145.52M
Long term investments - - - - -
Net tangible assets 155.04M 202.47M 157.25M 104.83M 109.11M
Short term investments -0.02300M 5.36M 10.75M 15.70M 19.67M
Net receivables - - 0.58M 1.44M 1.01M
Long term debt - - - - -
Inventory 118.86M 180.04M 53.39M 48.77M 38.89M
Accounts payable 58.67M 70.89M 35.77M 22.61M 60.32M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.02M 0.11M 0.04M 0.03M -0.17300M
Additional paid in capital - - - - -
Common stock total equity 0.01M 0.01M 0.01M 0.01M 0.01M
Preferred stock total equity - - - - -
Retained earnings total equity 139.85M 190.33M 154.35M 168.79M 131.34M
Treasury stock - - -5.00000M -63.99300M -30.87900M
Accumulated amortization - - - - -
Non currrent assets other 12.46M 6.47M 2.94M 0.35M 1.18M
Deferred long term asset charges - - - - 2.98M
Non current assets total 93.43M 91.46M 41.77M 40.50M 23.91M
Capital lease obligations 26.05M 32.54M 11.16M 13.60M -
Long term debt total 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 5.27M 5.14M 4.61M 3.73M 3.54M
Change to liabilities -36.22100M 54.38M 28.01M 12.11M 18.29M
Total cashflows from investing activities -11.41400M -29.06400M -1.28200M -6.32800M -1.19900M
Net borrowings - - - - -
Total cash from financing activities -199.58100M -125.13300M -57.14400M -82.32400M -53.32800M
Change to operating activities -3.31500M -14.43000M -2.27300M -1.50100M -0.21700M
Net income 143.57M 164.03M 102.86M 77.92M 55.79M
Change in cash -16.49200M -59.54000M 86.75M -4.39000M 6.29M
Begin period cash flow 104.18M 163.72M 76.97M 81.36M 75.08M
End period cash flow 87.69M 104.18M 163.72M 76.97M 81.36M
Total cash from operating activities 194.57M 94.55M 145.20M 84.26M 60.82M
Issuance of capital stock - - - - -
Depreciation 10.98M 6.81M 7.27M 4.62M 4.43M
Other cashflows from investing activities 5.27M 5.14M 4.61M 3.73M 0.20M
Dividends paid 71.62M 63.86M 53.19M 35.40M 23.16M
Change to inventory 61.19M -126.65100M -4.62100M -9.88300M -18.65800M
Change to account receivables - - 0.30M -4.06400M 0.12M
Sale purchase of stock -127.96100M -62.08800M -5.55100M -47.20600M -30.71500M
Other cashflows from financing activities -11.41400M 0.81M 1.60M 0.28M 0.55M
Change to netincome 12.26M 6.19M 8.16M 9.77M 0.49M
Capital expenditures 16.68M 34.21M 5.89M 10.06M 4.94M
Change receivables - - 0.30M -4.06400M 0.12M
Cash flows other operating 2.78M -10.30600M 2.90M -6.67000M -0.22000M
Exchange rate changes - - -0.02100M 0.00100M -0.00200M
Cash and cash equivalents changes -16.42500M -59.65200M 86.75M -4.39000M 6.29M
Change in working capital 21.65M -87.64600M 26.58M -8.50600M -0.46700M
Stock based compensation 11.05M 9.90M 6.80M 4.52M 3.12M
Other non cash items 8.24M 5.16M 1.09M 4.11M 0.62M
Free cash flow 177.89M 60.34M 139.31M 74.20M 55.88M

Peer Comparison

Sector: Consumer Cyclical Industry: Personal Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MED
MEDIFAST INC		 -0.62 3.49% 17.15 6.07 - 0.60 3.78 0.49 3.64
ROL
Rollins Inc		 0.04 0.08% 47.22 51.78 39.22 6.88 18.58 7.13 31.73
SCI
Service Corporation International		 0.40 0.49% 82.64 21.36 18.55 2.46 6.15 3.54 12.26
HRB
H&R Block Inc		 0.41 0.77% 53.90 13.51 11.21 1.96 26.62 2.38 8.97
BFAM
Bright Horizons Family Solutions Inc		 1.15 1.09% 106.18 56.55 29.24 2.50 4.79 3.21 25.53

Reports Covered

Stock Research & News

View All

Profile

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.

MEDIFAST INC

100 International Drive, Baltimore, MD, United States, 21202

Key Executives

Name Title Year Born
Mr. Daniel R. Chard Exec. Chairman & CEO 1965
Mr. James P. Maloney CPA Chief Financial Officer 1968
Mr. Anthony E. Tyree Chief Marketing Officer 1966
Mr. Nicholas M. Johnson Pres of Coach & Client Experience 1980
Ms. Lauren Walker Exec. VP of Supply Chain Operations 1967
Mr. Jonathan Barrett MacKenzie VP of Fin. & Chief Accounting Officer 1972
Mr. Jason L. Groves Esq. Exec. VP, Gen. Counsel & Corp. Sec. 1971
Ms. Claudia C. Greninger Exec. VP of HR 1973

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.